SCHEMBL3387003

SCHEMBL3387003

CC(C)[Si](C)(C)c1ccc(CNCCc2cccc(C(F)(F)F)c2)cc1.CC(C)[Si](C)(C)c1ccc(CNCCc2cccc(C(F)(F)F)c2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.53
TDP1 Q9NUW8 1/20 0.53
ROCK1 Q13464 1/20 0.53
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
PARP1 P09874 2/20 0.50
HTR2A P28223 3/20 0.48
HTR2B P41595 3/20 0.48
HTR2C P28335 3/20 0.48
SIGMAR1 Q99720 3/20 0.46
CYP2D6 P10635 2/20 0.46
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
TSHR P16473 1/20 0.46
CYP2C19 P33261 1/20 0.46
ADRA2C P18825 3/20 0.46
SLC6A4 P31645 3/20 0.46
DRD3 P35462 3/20 0.46
OPRK1 P41145 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3385717 1.00 KDM4E (0.53) KDM4ETDP1ROCK1MEN1KMT2A
SCHEMBL3917296 0.87 ROCK1 (0.60) KDM4ETDP1ROCK1MEN1KMT2A
SCHEMBL3386391 0.87 ROCK1 (0.60) KDM4ETDP1ROCK1MEN1KMT2A
SCHEMBL3581363 0.84 KDM4E (0.56) KDM4ETDP1ROCK1MEN1KMT2A
SCHEMBL9957537 0.82 KDM4E (0.59) KDM4ETDP1ROCK1MEN1KMT2A
SCHEMBL9958168 0.82 KDM4E (0.59) KDM4ETDP1ROCK1MEN1KMT2A
SCHEMBL3235999 0.81 KDM4E (0.58) KDM4ETDP1ROCK1MEN1KMT2A
Hydrochloric Acid SCHEMBL11847984 0.80 MEN1 (0.62) KDM4ETDP1ROCK1MEN1KMT2A
SCHEMBL5198980 0.80 KDM4E (0.60) KDM4ETDP1ROCK1MEN1KMT2A
SCHEMBL3574201 0.78 KDM4E (0.55) KDM4ETDP1ROCK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1984002-B1 TRIALKYLSILYLBENZYLAMINOCARBOXYINDOLES, INDAZOLES AND INDOLINES AND THEIR USE IN TREATING CETP-MEDIATED DISORDERS HOFFMANN LA ROCHE (CH) 2010-12-22 EP disclosed
US-7572823-B2 Heteroaryl carboxamide compounds HOFFMANN-LA ROCHE INC. (US) 2009-08-11 US disclosed